Ex vivo biologics characterization
Using our core characterization method AF4, we probe protein therapeutic characteristics and behavior in plasma, serum and whole blood – thus providing a route to investigate parenteral drugs in its intended in vivo application in an effort to improve patient cohort selection. This in order to maximize the positive impact of the drug while mitigating…